Tag Archive for: Bone Therapeutics

Clinical development of Bone Therapeutics' lead asset, the bone forming cell therapy ALLOB, will be discontinued. © Pixabay.com/virnuls
CGT

BioSenic halts ALLOB development

BioSenic SA has  suspended its Phase II proof-of-concept trial on fracture healing with its allogeneic cell therapy ALLOB.

Read more
In 2020, Catalent took over Bone Therapeutics' tcell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA, including all of its assets located in Gosselies, Belgium. © Bone Therapeutics
M&A

Bone Therapeutics merges with Medsenic and changes name

Bone Therapeutics has merged with French inflammatory/autoimmune company Medsenic in a €40m deal and changed its name into BioSenic.

 

Read more